You are here: Home What we do Medical & Pharma

Latest topics

Neuropathic pain (Qutenza) • ACE-I & hypertension • Ethilon • Psoriasis • Paediatric patients with spasticity • Surgicel • dupilumab in atopic dermatitis • Mepilex • Non-small-cell lung cancer • COPD • Fibroma & Endometriosis • Diabetic foot ulcer • Hypercholesterolemia • Direct-action antivirals (DAA) • Intermittent self catheterisation (ISC) • Chemotherapy induced anemia • Crohn’s disease • a/mNSCLC (IIIb/IV) • Somatuline • Zontivity • Metastatic melanoma • Cystic fibrosis • Nonvalvular Atrial Fibrillation (NVAF) & venous thromboembolism (VTE) • Januvia • Spiriva®, Respimat® & Striverdi® • NSCLC IIIb/V • Type-II Diabetes • Mylan • tralokinumab • Diabetes • Sanofi • “Difficult-to-treat” T2D patients • “Difficult-to-treat” type-II diabetes • Olodaterol • Hill's Vet Essentials • Excedrin • Jakavi (ruxolitinib) • Lebrikizumab • Multiple Myeloma • Intermittent self catheterisation • Maraviroc • Johnson & Johnson • MCI Healthcare • Hemophilia A / Kogenate • Diabetes • SpeediCath • VAC ULTA & VeraFlo • Boehringer • Excedrin • Mimpara • Neuraxial connectors • Prontalgine • Severe hypertriglyceridemia • Vaccins • OneTouch IQ & Glance • Inflammatory intestinal diseases / Crohn's disease • Harmonic Focus • RoActemra • Avastin • Dialysis machines • Avastin • Amgen • RoActemra • NSCLC • Sutent • Edwards SAPIEN XT Transcatheter Heart Valve • Rotarix • Xolair (omalizumab) • A new ICS+LABA against overlap asthma and COPD • Afinitor (Everolimus) • Soluprep IV Skin Prepping • Vaccin méningococcique Nimenrix • Ferinject in chemo-induced anemia • Humira • Rasilez (aliskiren) • Siemens radiology research • A new molecule against social impairment in Autism Spectrum Disorder (ASD) • Covidien, ev3, Bacchus, Trellis… • A new anti-PCSK9 monoclonal antibody reducing LDLc • Dolutegravir + Epzicom (abacavir, lamivudine) in HIV • Viread • Pertuzumab • Vemurafenib, BRAF inhibitor in metastatic melanoma • Pertuzumab • Hospital sterilisation equipment • Vascular access in patients with end-stage renal disease • Endoscopy towers • Muscular distrophy, BG-12, Nrf2 pathway • aHUS • Malignant melanoma • Thrombosis • Vfend • Cetuximab in head and neck cancer • Non-small-cell lung cancer • a new nucleoside polymerase inhibitor in development for treatment of chronic hepatitis C • Ustekinumab (Stelara) • Herceptin • Type-I diabetes • Acarbose (antidiabétique oral) • Atrial Fibrillation • Xelox • Iressa (gefitinib) • Chronic obstructive pulmonary disease (COPD) • Adelphi, Orencia, rhumatoid arthritis • Novartis, immuno-suppressants and transplants • Immunosuppressant therapy • Ovarian cancer • Chronic Kidney Disease (CKD) and hyperphosphataemia (HPP) • Atripla - HIV • Adjuvant and metastatic Breast Cancer • RebiSmart • Tyverb - lapatinib • Arixtra • Risperdal Consta • G-CSF in HIV treatment • Osteopososis • Nutropin GHT • Adelphi, Revlimid, Multiple myeloma • Ferinject, IV treatment for iron deficiency • Orencia, rhumatoid arthritis treatment • Gastric Reflux • Vidaza • Rhumatoid arthritis • COPD • Glucophage soluble • Insomnia • Parkinson's disease, Adelphi, Stalevo • Diabète de type-II • Chemotherapy-induced thrombopenia • Renal Dysfunction

You are here: Home What we do Medical & Pharma